a developer of therapies that harness the patient's immune system to treat cancer
Industry Biotechnology
A.I.dvisor indicates that over the last year, INMB has been loosely correlated with MDGL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if INMB jumps, then MDGL could also see price increases.
Ticker / NAME | Correlation To INMB | 1D Price Change % | ||
---|---|---|---|---|
INMB | 100% | -2.72% | ||
MDGL - INMB | 41% Loosely correlated | -0.55% | ||
ORMP - INMB | 38% Loosely correlated | +0.42% | ||
AXON - INMB | 37% Loosely correlated | -1.54% | ||
CYTK - INMB | 34% Loosely correlated | -3.46% | ||
PRME - INMB | 32% Poorly correlated | -10.54% | ||
More |